Hyperkalemia: Pharmacotherapies and Clinical Considerations.
Evan S Sinnathamby, Kelly T Banh, William T Barham...
https://pubmed.ncbi.nlm.nih.gov/38406030/Actively Recruiting
Led by Xiujuan Zang · Updated on 2025-07-11
1890
Participants Needed
1
Research Sites
8 weeks
Total Duration
Researchers are investigating how common hyperkalemia is and what risk factors contribute to it among patients with chronic kidney disease CKD who are not on dialysis. This observational study focuses on people receiving primary care in the community and aims to improve understanding by collecting detailed clinical and lifestyle information. The study is being conducted across 18 community health centers and hopes to create a risk prediction model to guide better screening and management of hyperkalemia in CKD patients. The study includes two phases an initial validation phase with 500 participants to check the accuracy of point-of-care testing POCT devices measuring blood potassium, glucose, creatinine, uric acid, and hemoglobin, followed by a main phase with 1,500 participants to assess hyperkalemia prevalence and related risk factors. Blood samples are collected for both POCT and laboratory testing, and participants complete structured questionnaires about their demographics, health conditions, and lifestyle habits. No treatments or interventions are given, as this is an observational study. Participants provide blood samples and answer interviews or questionnaires during their enrollment visit. Researchers measure potassium levels and other blood markers using both POCT and laboratory methods. They also collect data on age, CKD stage, and other health factors to analyze their connection to hyperkalemia. The main outcome is the prevalence of hyperkalemia at enrollment. The study findings will help develop a predictive model to improve early detection and management of hyperkalemia in community-based CKD care.
CONDITIONS
Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community
X
Xiujuan Zang, MD
X
Xiangyu Zhang, MMed
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Xiujuan Zang
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo point-of-care testing (POCT) and laboratory blood tests, and complete structured questionnaires to collect data on potassium levels, kidney function, and other health indicators.
1 visit (in-person)
Duration - At the time of enrollment
Participants are observed to assess the prevalence and risk factors of hyperkalemia based on collected data without any intervention.
No additional visits
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Evan S Sinnathamby, Kelly T Banh, William T Barham...
https://pubmed.ncbi.nlm.nih.gov/38406030/Bogdan Ene-Iordache, Norberto Perico, Boris Bikbov...
https://pubmed.ncbi.nlm.nih.gov/27102194/Lisa M Einhorn, Min Zhan, Van Doren Hsu...
https://pubmed.ncbi.nlm.nih.gov/19546417/Luca De Nicola, Luca Di Lullo, Ernesto Paoletti...
https://pubmed.ncbi.nlm.nih.gov/29882199/Chadapa Sevamontree, Supreeya Jintajirapan, Pran Phakdeekitcharoen...
https://pubmed.ncbi.nlm.nih.gov/38292832/Luxia Zhang, Fang Wang, Li Wang...
https://pubmed.ncbi.nlm.nih.gov/22386035/John R Montford, Stuart Linas
https://pubmed.ncbi.nlm.nih.gov/28778861/Sarah Gilligan, Kalani L Raphael
https://pubmed.ncbi.nlm.nih.gov/29031358/Xiujuan Zang
Lead Sponsor